Clin2
NCT06787118Possibly a fitNot yet recruiting

Cannabidiol oral solution for joint pain from hormone therapy in early breast cancer

Breast Cancer Stage IBreast Cancer Stage IIBreast Cancer Stage IIIHR+ Breast CancerAI-related Musculoskeletal Pain

Part of Cancer, Skin clinical trials.

This trial tests an oral solution of cannabidiol (CBD), a non-psychoactive cannabis compound, to see if it can ease joint pain caused by aromatase inhibitor therapy for early breast cancer. If it works, it could offer a new way to manage this common side effect.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
130 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have been diagnosed with early-stage (I, II, or III) hormone-positive breast cancer.
  • You have been taking an aromatase inhibitor (such as anastrozole, exemestane, or letrozole) for at least 3 weeks but no longer than 3 years.
  • You are experiencing joint pain rated 4 or higher on a 0-10 scale, where 0 is no pain and 10 is the worst pain imaginable.
  • You have not used opioids (strong painkillers like morphine), NSAIDs (like ibuprofen), or steroid medications for joint pain in the past 28 days.
  • Your liver, kidney, and heart function are within acceptable ranges as determined by blood tests and an ECG.
  • You are willing to use highly effective contraception (if of childbearing potential) and avoid becoming pregnant or fathering a child during the trial and for 3 months after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07859319Not yet recruiting· Phase 4
Herbal supplement for joint pain from breast cancer hormone therapy

This trial tests a plant-based supplement (devil's claw, blackcurrant, and meadowsweet) to see if it can reduce joint pain caused by hormone therapy for breast cancer. If you have joint pain from your hormone treatment, this study might help you find a natural way to ease it.

Bron
NCT06831838Recruiting
Pain management program for breast cancer survivors with joint pain

This trial tests a cognitive behavioral therapy (CBT) based program to help relieve joint and muscle pain caused by aromatase inhibitors, a common hormone therapy for breast cancer. It aims to improve your quality of life and reduce symptoms.

Jacksonville, Florida
NCT07825454Not yet recruiting· Phase 2
Hydroxychloroquine for joint and muscle pain from hormone therapy

This study tests whether hydroxychloroquine, a medicine used for autoimmune conditions, can reduce joint and muscle pain caused by aromatase inhibitors, which are common hormone therapies for breast cancer. If you have bothersome pain from your hormone therapy, this study may help you find relief.

Indianapolis, Indiana
NCT07409948Not yet recruiting
Combined program for joint and muscle pain from breast cancer hormone therapy

This study tests a program of care to help with joint and muscle pain caused by aromatase inhibitor therapy, a common treatment for breast cancer. It aims to reduce pain and improve quality of life for people taking these medications.

NCT06214598Recruiting
Anti-inflammatory diet for breast cancer patients on hormone therapy

This study tests whether a special anti-inflammatory diet can help reduce side effects in breast cancer survivors who are taking aromatase inhibitors after menopause. You would be randomly assigned to either follow the diet for 6 months or continue your usual diet, and your health will be monitored.

Belgrade
NCT06123286Recruiting· Early Phase 1
Tart cherry and omega-3s for joint pain from hormone therapy

This study tests whether taking tart cherry and omega-3 supplements can help reduce joint pain and stiffness caused by aromatase inhibitors (a common breast cancer treatment). If you have bothersome joint pain while on this hormone therapy, you may be able to join.

Los Angeles, California

Hear when a new Breast Cancer Stage I trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.